Clinical trial abstracts posted Thursday ahead of this year’s ASCO meeting gave a peek at anticipated datasets from Merck, ...

Novel CRISPR-Cas9 treatments are proving effective in reversing disease for life. But ensuring their long-term safety will ...

In high-risk patients without prior heart attack or stroke who underwent percutaneous coronary intervention, evolocumab ...

AstraZeneca Plc won the endorsement of an advisory panel to the European Medicines Agency for a new breast cancer medicine ...

The cutaneous T-cell lymphoma clinical trial analysis report delivers important insights into ongoing research of 30+ ...

FDA approves VEPPANU (vepdegestrant), the first PROTAC therapy for ESR1 mutated metastatic breast cancer. Approval sets a new treatment class for a genetic subgroup that has had limited targeted ...

Pfizer PFE is one of the world’s leading oncology drugmakers, with a strong presence across breast, genitourinary, thoracic, ...

Pfizer Inc. said a new version of its bestselling Prevnar vaccine may provide infants with better protection against common ...

Mark Cuban emphasized bipartisan support for lower drug prices, despite earlier opposition to Trump. The website lists ...

The anticipated FDA approval of brepocitinib signals an important shift in dermatomyositis management, according to a speaker ...

In my March article, "Why Pfizer Remains A Strong Buy In 2026", I mainly discussed Pfizer's Q4 earnings ( PFE) and the ...